STOCK TITAN

Bwx Technologies Inc SEC Filings

BWXT NYSE

Welcome to our dedicated page for Bwx Technologies SEC filings (Ticker: BWXT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Tracking the Navy’s next-generation submarine reactors, monitoring radiopharmaceutical rollouts, and dissecting multi-billion-dollar government contracts—BWX Technologies’ disclosures aren’t light reading. Each 300-page 10-K is dense with classified-adjacent cost structures and environmental liability tables that leave even seasoned analysts scrolling for hours.

Stock Titan solves that problem. Our AI distills every BWX Technologies annual report 10-K simplified, flags section-by-section risks, and links them to prior guidance so you instantly see what changed. Need the latest BWX Technologies quarterly earnings report 10-Q filing? We post it in real time, then generate a side-by-side earnings report filing analysis that highlights reactor production milestones and radiopharmaceutical revenue. Form 4 insider transactions real-time alerts let you know the moment an executive stock transaction hits EDGAR, while our dashboard groups every BWX Technologies insider trading Form 4 transactions by officer to reveal buying or selling trends before material events.

Whether you’re understanding BWX Technologies SEC documents with AI for the first time or drilling into a specific BWX Technologies proxy statement executive compensation table, you’ll find every filing type—8-K material events explained, prospectuses, tender offers, even technical 11-K benefit-plan reports—indexed, summarized, and cross-referenced. Investors use these insights to:

  • Compare contract backlog shifts quarter-over-quarter
  • Monitor BWX Technologies executive stock transactions Form 4 for confidence signals
  • Track environmental remediation reserves across reporting periods
Complex nuclear disclosures, clarified. All on one page, updated the moment BWXT hits EDGAR.

Rhea-AI Summary

BWX Technologies (BWXT) insider filing: On 10/24/2025, the company’s VP & Chief Accounting Officer reported the vesting and settlement of 1,795 RSUs into common stock at an exercise price of $0 (coded “M”). To cover taxes, 719 shares were withheld (coded “F”) at $199.92 per share. Following these transactions, the reporting person directly owned 3,618 common shares.

The RSUs vest in three equal annual installments beginning October 24, 2023, and the derivative balance for this RSU grant is now shown as 0.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Nicole W. Piasecki, a director of BWX Technologies, Inc. (BWXT), reported a Form 4 filing related to dividend equivalent rights on restricted stock units. The Form 4 shows a transaction dated 09/05/2025 in which dividend equivalent rights (DERs) were recorded as acquired (code A) representing 5.74 underlying shares of common stock at a $0 price. The filing states these DERs accrued on three restricted stock unit grants for which the reporting person elected to defer receipt; each RSU and DER is a contingent right to receive one share and the DERs will be delivered proportionately with the related RSUs. The report indicates 36.53 shares of common stock beneficially owned following the transaction. The Form 4 is signed by an attorney-in-fact on behalf of Ms. Piasecki on 09/08/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.07%
Tags
insider
-
Rhea-AI Summary

Jan A. Bertsch, a director of BWX Technologies, Inc. (BWXT), reported a transaction dated 09/05/2025 in which 36 dividend equivalent rights (DERs) tied to deferred restricted stock units (RSUs) were acquired. Each DER and RSU represents a contingent right to one share of BWXT common stock and the DERs have a reported price of $0. Following the reported transaction the filing shows 2,142.67 shares beneficially owned. The DERs relate to eight RSU grants for which the reporting person elected deferral; the DERs will be delivered proportionately with the underlying RSUs. The Form 4 is signed on behalf of Mr. Bertsch by an attorney-in-fact on 09/08/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.07%
Tags
insider
Rhea-AI Summary

Gerhard F. Burbach, a director of BWX Technologies, Inc. (BWXT), reported a Section 16 transaction dated 09/05/2025. The filing shows the accrual and acquisition of 19.4 dividend equivalent rights related to six restricted stock unit (RSU) grants for which the reporting person elected to defer receipt of the underlying shares. Each RSU and dividend equivalent right (DER) represents a contingent right to one share of BWXT common stock. The DERs have a reported price of $0 and, per the deferral election, will be delivered proportionately with the related RSUs. The filing lists 723.65 shares as the amount beneficially owned following the reported transaction. The form is signed on behalf of Mr. Burbach by an attorney-in-fact.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.07%
Tags
insider
-
Rhea-AI Summary

John M. Richardson, a director of BWX Technologies, Inc. (BWXT), filed a Form 4 disclosing a transaction dated 09/05/2025. The filing reports the acquisition of dividend equivalent rights (DERs) that accrued on four restricted stock unit (RSU) grants for which the reporting person elected to defer receipt of the underlying shares. Each RSU and each DER is described in the filing as a contingent right to receive one share of BWXT common stock. The reported transaction shows a price of $0 and indicates 300 shares beneficially owned following the transaction (ownership listed as direct). The Form 4 is signed on behalf of Mr. Richardson by an attorney-in-fact on 09/08/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.07%
Tags
insider
-
Rhea-AI Summary

Insider Form 4 summary for BWXT

Director Leland D. Melvin (reported as "Melvin Leland D") reported a transaction dated 09/05/2025 reflecting the acquisition of 12.51 dividend equivalent rights (DERs) tied to four restricted stock unit (RSU) grants. Each DER and each RSU represent a contingent right to one share of BWXT common stock and, per Mr. Melvin's deferral election, the DERs will be delivered proportionately with the underlying RSUs. After this reported transaction the filing shows 192.97 shares beneficially owned in direct form. The Form 4 was signed by an attorney-in-fact on 09/08/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.07%
Tags
insider
Rhea-AI Summary

James M. Jaska, a director of BWX Technologies (BWXT), recorded a transaction dated 09/05/2025 reflecting dividend equivalent rights (DERs) accrued on seven restricted stock units (RSUs) for which he elected to defer receipt. Each RSU and associated DER represent a contingent right to one share of BWXT common stock. The DERs will be delivered proportionately with the underlying RSUs. The filing shows an acquisition of 23.91 dividend equivalent rights and reports 1,043.71 shares beneficially owned by the reporting person following the transaction. The transaction price is reported as $0, consistent with dividend-equivalent crediting rather than a cash purchase.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.07%
Tags
insider
-
Rhea-AI Summary

Kenneth J. Krieg, a director of BWX Technologies, Inc. (BWXT), reported a change in beneficial ownership on Form 4 related to dividend equivalent rights tied to deferred restricted stock units. The filing shows a transaction dated 09/05/2025 in which Dividend Equivalent Rights (DERs) were acquired at a reported price of $0. The explanation states these DERs accrued on nine restricted stock unit grants for which the reporting person elected to defer receipt of the underlying shares. Each RSU and DER represents a contingent right to receive one share of BWXT common stock, and the DERs will be delivered proportionately with the related RSUs. The table lists amounts including 32.04 (DERs) and a post-transaction beneficial ownership figure of 1,362.98.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.07%
Tags
insider
-
Filing
Rhea-AI Summary

BWX Technologies, Inc. (BWXT) Form 144 notice reports a proposed sale of 4,571 shares of common stock through Charles Schwab & Co., Inc. with an approximate sale date of 09/04/2025. The filer acquired these shares on 08/29/2025 by restricted stock lapse from BWX Technologies, Inc. and lists the nature of payment as equity compensation. The aggregate market value of the proposed sale is shown as $743,556.00 against 91,398,740 shares outstanding. The form states there were no securities sold by the filer in the past three months and includes the required representation that the filer is unaware of undisclosed material adverse information.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Summary

Leland D. Melvin, identified as a director of BWX Technologies, Inc. (BWXT), reported a sale of 600 common shares on 08/11/2025 at a price of $178.265, leaving beneficial ownership of 5,579 shares. The Form 4 was executed by attorney-in-fact Theresa B. Taylor and signed on 08/12/2025. No derivative transactions were reported.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

What is the current stock price of Bwx Technologies (BWXT)?

The current stock price of Bwx Technologies (BWXT) is $207.62 as of October 28, 2025.

What is the market cap of Bwx Technologies (BWXT)?

The market cap of Bwx Technologies (BWXT) is approximately 18.6B.
Bwx Technologies Inc

NYSE:BWXT

BWXT Rankings

BWXT Stock Data

18.65B
91.03M
0.4%
97.3%
2.74%
Aerospace & Defense
Engines & Turbines
Link
United States
LYNCHBURG